ERBB2 and gastric carcinoma: Furthermore, the potential of the IF and FISH combination was further exemplified by using a combination of cytokeratin antibody and a HER2 FISH probe on gastric carcinomas and a CD30 antibody and an IgH probe for lymphoma studies [15].